About Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
The Maria Sklodowska-Curie National Research Institute of Oncology is a specialized research institute and hospital of the Polish Ministry of Health. Based in Warsaw, it also has regional branches in Gliwice and Kraków.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
4
Clinical Trials at Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
During the past decade, Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
2019-10-28
2027-06-29
Active, not recruiting
790
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
According to Clinical.Site data, the most researched conditions in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" are
"Melanoma" (4 trials) and "Skin Cancer" (1 trials). Many other conditions were trialed in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" in a lesser frequency.
Clinical Trials Intervention Types at Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
Most popular intervention types in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" are "Biological" (4 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (2 trials), "Placebo" (2 trials), "BMS-986205" (1 trials), "Ipilimumab 1 mg/kg IV" (1 trials) and "Ipilimumab 3 mg/kg IV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
The vast majority of trials in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" are
4 trials for "All" genders.
Clinical Trials Status at Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow
Currently, there are NaN active trials in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".